• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿外泌体 microRNA-21 在膀胱癌早期诊断和预后中的价值。

The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer.

机构信息

Department of Urology, Guangdong Medical University, Zhanjiang, China.

Department of Urology, Yuebei people's hospital, Shaoguan, China.

出版信息

Kaohsiung J Med Sci. 2024 Jul;40(7):660-670. doi: 10.1002/kjm2.12845. Epub 2024 May 27.

DOI:10.1002/kjm2.12845
PMID:38801488
Abstract

Bladder cancer (BC) poses high morbidity and mortality, with urinary exosomal microRNA (miR)-21 showing potential value in its diagnosis and prognosis, and we probed its specific role. We prospectively selected 116 BC patients and 116 healthy volunteers as the BC and control groups, respectively. BC urinary exosomal miR-146a-5p, miR-93-5p, miR-663b, miR-21, and miR-4454 relative expression levels were assessed. The correlations between clinical indexes and urinary exosomal miR-21, prognostic value of miR-21, and diagnostic value of the five candidate miRNAs, urine cytology, and miRNA joint diagnostic panel for BC and urinary exosomal miR-21, miR-4454, and urine cytology for Ta-T1 and T2-T4 stage BC were analyzed. Urinary exosomal miR-146a-5p, miR-93-5p, miR-663b, miR-21, and miR-4454 were highly expressed in BC patients. miR-146a-5p, miR-93-5p, miR-663b, miR-21, miR-4454, miRNA combined diagnostic panel, and urine cytology had certain diagnostic value for BC, with miR-21, miR-4454, and miRNA co-diagnostic panel showing the highest diagnostic value. Collectively, urinary exosomal miR-21 was closely related to Tumor-Node-Metastasis staging and grading in BC patients. Urinary exosomal miR-21 had high diagnostic value for BC and Ta-T1 and T2-T4 stage BC, and had high predictive value for BC poor prognosis, providing an effective indicator for the occurrence, development, and prognostic assessment of BC.

摘要

膀胱癌(BC)发病率和死亡率高,尿外泌体 microRNA(miR)-21 在其诊断和预后中有潜在价值,本研究旨在探究其具体作用。前瞻性选择 116 例 BC 患者和 116 例健康志愿者分别作为 BC 组和对照组,评估 BC 患者尿外泌体 miR-146a-5p、miR-93-5p、miR-663b、miR-21 和 miR-4454 的相对表达水平。分析临床指标与尿外泌体 miR-21 的相关性、miR-21 的预后价值、5 个候选 miRNA、尿细胞学和 miRNA 联合诊断.panel 对 BC 的诊断价值,以及尿外泌体 miR-21、miR-4454 和尿细胞学对 Ta-T1 和 T2-T4 期 BC 的诊断价值。BC 患者的尿外泌体 miR-146a-5p、miR-93-5p、miR-663b、miR-21 和 miR-4454 表达水平均升高。miR-146a-5p、miR-93-5p、miR-663b、miR-21、miR-4454、miRNA 联合诊断 panel 和尿细胞学对 BC 具有一定的诊断价值,其中 miR-21、miR-4454 和 miRNA 联合诊断 panel 的诊断价值最高。综上所述,BC 患者尿外泌体 miR-21 与肿瘤-淋巴结-转移分期和分级密切相关。尿外泌体 miR-21 对 BC 及 Ta-T1 和 T2-T4 期 BC 具有较高的诊断价值,对 BC 预后不良具有较高的预测价值,为 BC 的发生、发展和预后评估提供了有效的指标。

相似文献

1
The value of urinary exosomal microRNA-21 in the early diagnosis and prognosis of bladder cancer.尿外泌体 microRNA-21 在膀胱癌早期诊断和预后中的价值。
Kaohsiung J Med Sci. 2024 Jul;40(7):660-670. doi: 10.1002/kjm2.12845. Epub 2024 May 27.
2
Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.尿外泌体 microRNA-96-5p 和 microRNA-183-5p 表达作为膀胱癌潜在生物标志物。
Mol Biol Rep. 2021 May;48(5):4361-4371. doi: 10.1007/s11033-021-06451-5. Epub 2021 Jun 4.
3
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.尿外泌体 miRNA 作为膀胱癌的生物标志物及 miR-93-5p 在膀胱癌中作用机制的实验验证。
BMC Cancer. 2021 Dec 3;21(1):1293. doi: 10.1186/s12885-021-08926-x.
4
Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.尿 microRNA 表达和蛋白浓度可能有助于区分膀胱癌患者与健康对照者。
Int Urol Nephrol. 2020 Mar;52(3):461-468. doi: 10.1007/s11255-019-02328-6. Epub 2019 Nov 2.
5
Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.检测四个血清 microRNA 标志物panel 对原发性膀胱癌检测的准确性:一项发现和验证研究。
Biomarkers. 2024 Jul;29(5):276-284. doi: 10.1080/1354750X.2024.2358312. Epub 2024 May 30.
6
Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.尿液中无细胞微小RNA表达特征可作为膀胱癌诊断和复发预测的新型非侵入性生物标志物。
Oncotarget. 2017 Jun 20;8(25):40832-40842. doi: 10.18632/oncotarget.16586.
7
MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.肿瘤样本和尿液细胞外囊泡中的 microRNAs 作为肌肉浸润性膀胱癌的一种潜在诊断工具。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2725-2736. doi: 10.1007/s00432-019-03035-6. Epub 2019 Sep 24.
8
Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.外泌体 miR-663b 通过靶向 Ets2 抑制因子促进膀胱癌细胞的增殖和上皮间质转化。
Cell Biol Int. 2020 Apr;44(4):958-965. doi: 10.1002/cbin.11292. Epub 2020 Jan 6.
9
A urinary microRNA (miR) signature for diagnosis of bladder cancer.用于诊断膀胱癌的尿液微小RNA(miR)特征
Urol Oncol. 2018 Dec;36(12):531.e1-531.e8. doi: 10.1016/j.urolonc.2018.09.006. Epub 2018 Oct 12.
10
Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its Target Gene ARID4B and Regulating the Immune Microenvironment.尿液外泌体miR-17-5p通过抑制其靶基因ARID4B和调节免疫微环境促进膀胱癌侵袭。
Clin Genitourin Cancer. 2024 Apr;22(2):569-579.e1. doi: 10.1016/j.clgc.2024.01.012. Epub 2024 Jan 22.

引用本文的文献

1
Tumor-derived exosomes and their application in cancer treatment.肿瘤衍生的外泌体及其在癌症治疗中的应用。
J Transl Med. 2025 Jul 8;23(1):751. doi: 10.1186/s12967-025-06814-7.
2
Recent Exploration of Solid Cancer Biomarkers Hidden Within Urine or Blood Exosomes That Provide Fundamental Information for Future Cancer Diagnostics.近期对尿液或血液外泌体中隐藏的实体癌生物标志物的探索,这些生物标志物为未来癌症诊断提供基础信息。
Diagnostics (Basel). 2025 Mar 5;15(5):628. doi: 10.3390/diagnostics15050628.
3
Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?

本文引用的文献

1
Impact of three miRNA signature as potential diagnostic marker for triple negative breast cancer patients.三种 miRNA 特征作为三阴性乳腺癌患者潜在诊断标志物的影响。
Sci Rep. 2023 Dec 8;13(1):21643. doi: 10.1038/s41598-023-48896-7.
2
Cancer-Associated Fibroblast-Derived miR-146a-5p Generates a Niche That Promotes Bladder Cancer Stemness and Chemoresistance.癌症相关成纤维细胞衍生的 miR-146a-5p 产生促进膀胱癌干细胞特性和化疗耐药性的微环境。
Cancer Res. 2023 May 15;83(10):1611-1627. doi: 10.1158/0008-5472.CAN-22-2213.
3
Exosomal miR-93-5p as an important driver of bladder cancer progression.
膀胱癌中的非编码RNA,肠道微生物群与宿主之间的桥梁?
Front Immunol. 2024 Nov 19;15:1482765. doi: 10.3389/fimmu.2024.1482765. eCollection 2024.
4
The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis.尿液衍生外泌体诊断膀胱癌的准确性:系统评价和荟萃分析。
World J Surg Oncol. 2024 Oct 29;22(1):285. doi: 10.1186/s12957-024-03569-1.
5
Recent Electrochemical Advancements for Liquid-Biopsy Nucleic Acid Detection for Point-of-Care Prostate Cancer Diagnostics and Prognostics.近期液体活检核酸检测在即时前列腺癌诊断和预后中的电化学进展。
Biosensors (Basel). 2024 Sep 14;14(9):443. doi: 10.3390/bios14090443.
外泌体miR-93-5p作为膀胱癌进展的重要驱动因素。
Transl Androl Urol. 2023 Feb 28;12(2):286-299. doi: 10.21037/tau-22-872. Epub 2023 Feb 23.
4
miR-221-5p and miR-186-5p Are the Critical Bladder Cancer Derived Exosomal miRNAs in Natural Killer Cell Dysfunction.miR-221-5p 和 miR-186-5p 是自然杀伤细胞功能障碍中膀胱癌来源外泌体 miRNA 的关键。
Int J Mol Sci. 2022 Dec 2;23(23):15177. doi: 10.3390/ijms232315177.
5
Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.全面研究与细胞周期通路相关的基因,以预测和免疫治疗膀胱癌。
J Environ Pathol Toxicol Oncol. 2022;41(3):1-12. doi: 10.1615/JEnvironPatholToxicolOncol.2022041342.
6
A Liquid Biopsy in Bladder Cancer-The Current Landscape in Urinary Biomarkers.膀胱癌的液体活检——尿液生物标志物的现状。
Int J Mol Sci. 2022 Aug 2;23(15):8597. doi: 10.3390/ijms23158597.
7
Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.尿外泌体 miRNA 作为膀胱癌的生物标志物及 miR-93-5p 在膀胱癌中作用机制的实验验证。
BMC Cancer. 2021 Dec 3;21(1):1293. doi: 10.1186/s12885-021-08926-x.
8
The genetic source tracking of human urinary exosomes.人类尿外泌体的遗传来源追踪。
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43). doi: 10.1073/pnas.2108876118.
9
Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer.单细胞 RNA 测序揭示了人类膀胱癌上皮细胞的异质性和侵袭亚群。
Int J Cancer. 2021 Dec 15;149(12):2099-2115. doi: 10.1002/ijc.33794. Epub 2021 Sep 16.
10
Sample size determination and power analysis using the G*Power software.使用 G*Power 软件进行样本量确定和功效分析。
J Educ Eval Health Prof. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. Epub 2021 Jul 30.